Related Experiment Video
Updated: Jul 14, 2025

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
[Basics for the Use of Andexanet]
J Koscielny1, I Birschmann2, R Bauersachs3,4
1Charité, Universitätsmedizin Berlin, Gerinnungsambulanz mit Hämophiliezentrum, Berlin, Germany.
For severe bleeding associated with direct oral anticoagulants, specific reversal agents like andexanet are available. Prompt resumption of anticoagulation after hemostasis is crucial, balancing bleeding and thromboembolic risks.
Area of Science:
- Hematology
- Pharmacology
- Clinical Medicine
Context:
- Direct oral anticoagulants (DOACs) like rivaroxaban and apixaban are widely used for anticoagulation.
- Life-threatening bleeding can occur in patients taking DOACs.
- Reversal agents such as andexanet are available for specific DOACs.
Purpose:
- To provide evidence-based recommendations for managing severe bleeding in patients on DOACs.
- To guide the appropriate use of reversal agents like andexanet.
- To facilitate prompt and safe resumption of anticoagulation after bleeding events.
Summary:
- Severe bleeding in patients on DOACs necessitates consideration of reversal agents, particularly in cases of life-threatening hemorrhage, intracranial bleeding, or unstoppable gastrointestinal bleeding.
- Andexanet is indicated for reversal of anticoagulation in patients treated with rivaroxaban or apixaban experiencing severe bleeding.
- Following successful hemostasis, anticoagulation should be resumed promptly, carefully weighing the patient's individual risks of bleeding and thrombosis.
Impact:
- Improved management of bleeding emergencies in patients on DOACs.
- Standardized approach to the use of reversal agents, enhancing patient safety.
- Facilitation of interdisciplinary collaboration for optimal patient care during anticoagulation-related bleeding events.
More Related Videos
12:30Avidity-based Extracellular Interaction Screening AVEXIS for the Scalable Detection of Low-affinity Extracellular Receptor-Ligand Interactions
Published on: March 5, 2012
12:30Vascular Gene Transfer from Metallic Stent Surfaces Using Adenoviral Vectors Tethered through Hydrolysable Cross-linkers
Published on: August 12, 2014
Related Concept Videos
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Parenteral Anesthetics: Overview
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Drug Delivery: Enteral Route